Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
Pharmacology, Toxicology and Pharmaceutical Science
6
15%
Medicine and Dentistry
4
10%
Nursing and Health Professions
2
5%
Arts and Humanities
1
3%
Biochemistry, Genetics and Molecular Biology
1
3%
Other
4
10%
Unknown
22
55%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2026.
All research outputs
#6,545,777
of 34,566,597 outputs
Outputs from Therapeutic Drug Monitoring
#231
of 2,259 outputs
Outputs of similar age
#75,255
of 378,722 outputs
Outputs of similar age from Therapeutic Drug Monitoring
#1
of 12 outputs
Altmetric has tracked 34,566,597 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,259 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,722 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.
